West Pharmaceutical shareholders approve all proposals at 2025 annual meeting; adopt special meeting right

WEST PHARMACEUTICAL SERVICES INC

Shareholders elected all 12 director nominees; highest vote against was Deborah Keller (7.4M against).
Advisory vote on executive compensation approved with 59.2M for, 3.5M against (91.4% support).
Articles amended to allow shareholders to call special meetings, approved with 62.7M for (99.9% for).
2016 Omnibus Incentive Compensation Plan amended and restated, approved with 60.9M for (97.0% for).
PricewaterhouseCoopers ratified as auditor for 2025 with 60.5M for, 4.4M against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.